ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Sign Up

Already a member? Sign in

Top Brokers

More Brokers

Market Data
News
Trading Tools
Markets
Discover

Hot Features

Follow Feed

Connect with traders and investors in our Follow Feed community.

Options Flow

Explore comprehensive options data and use advanced filters with Options Flow.

Monitor

Organize and monitor your stock and asset watchlist with Monitor.
Sign In Premium IconPremium Help Menu
FTSE 100
8,191.29
0.60%
Dow Jones
38,834.86
0.15%
Gold vs US Dollar
2,330.40
0.43%
Brent Oil
84.815
0.04%
Bitcoin
65,143.77
0.01%
Pepperstone
Advertisement
Registration Strip Icon for monitor Customisable watchlists with full streaming quotes from leading exchanges, such as LSE, NASDAQ, NYSE, AMEX, Bovespa, BIT and more.
Get Started
  1. Home
  2. Investing
  3. Stocks
  4. USA
  5. NASDAQ
  6. Adial Pharmaceuticals Inc (ADILW)

  7. Adial Pharmaceuticals Inc (ADILW) News

Adial Pharmaceuticals (ADILW)

Adial Pharmaceuticals Inc
Date:
Sort by:
 Showing the most relevant articles for your search:NASDAQ:ADILW
DateTimeSourceHeadlineSymbolCompany
05/06/202413:30GlobeNewswire Inc.Adial Pharmaceuticals Achieves Important Milestone of First Patient Dosed in Pharmacokinetics Study of AD04 for the Treatment of Alcohol Use DisorderNASDAQ:ADILWAdial Pharmaceuticals Inc
29/05/202413:30GlobeNewswire Inc.Adial CEO to Present at the Spring MicroCap Rodeo Conference on June 6thNASDAQ:ADILWAdial Pharmaceuticals Inc
15/05/202413:30GlobeNewswire Inc.Adial Pharmaceuticals Reports First Quarter 2024 Financial Results and Provides Business UpdateNASDAQ:ADILWAdial Pharmaceuticals Inc
22/04/202413:30GlobeNewswire Inc.Adial Pharmaceuticals Granted Key Patent from the United States Patent and Trademark OfficeNASDAQ:ADILWAdial Pharmaceuticals Inc
10/04/202413:30GlobeNewswire Inc.Adial Pharmaceuticals Announces Peer-Reviewed Publication Highlighting Promising Safety Data and High Patient Compliance in a Clinical Trial of AD04 as a Potential Treatment for Alcohol Use DisorderNASDAQ:ADILWAdial Pharmaceuticals Inc
02/04/202413:30GlobeNewswire Inc.Adial Pharmaceuticals Reports 2023 Fiscal Year Financial Results and Provides Business UpdateNASDAQ:ADILWAdial Pharmaceuticals Inc
02/03/202400:00GlobeNewswire Inc.Adial Pharmaceuticals Announces Exercise of Warrants for $3.5 Million Gross ProceedsNASDAQ:ADILWAdial Pharmaceuticals Inc
28/02/202414:30GlobeNewswire Inc.Adial Pharmaceuticals Awarded New Patent from the United States Patent and Trademark OfficeNASDAQ:ADILWAdial Pharmaceuticals Inc
13/02/202414:15GlobeNewswire Inc.Adial Pharmaceuticals Awarded New Patent Notice of Allowance from the United States Patent and Trademark OfficeNASDAQ:ADILWAdial Pharmaceuticals Inc
18/01/202413:30GlobeNewswire Inc.Adial Announces Appointment of Tony Goodman as Chief Operating OfficerNASDAQ:ADILWAdial Pharmaceuticals Inc
20/12/202314:00GlobeNewswire Inc.Adial Pharmaceuticals Receives Final Reimbursement Payment from AdovateNASDAQ:ADILWAdial Pharmaceuticals Inc
29/11/202321:05GlobeNewswire Inc.Adial Pharmaceuticals Regains Compliance with Nasdaq Listing RequirementNASDAQ:ADILWAdial Pharmaceuticals Inc
14/11/202322:02GlobeNewswire Inc.Adial Pharmaceuticals Reports Third Quarter 2023 Financial Results and Provides Business UpdateNASDAQ:ADILWAdial Pharmaceuticals Inc
31/10/202312:30GlobeNewswire Inc.Adial Pharmaceuticals Chief Medical Officer and Key Opinion Leaders to Discuss “New Aspects in Substance Use Treatment” at The Annual International Society of Addiction Medicine ConferenceNASDAQ:ADILWAdial Pharmaceuticals Inc
25/10/202313:00GlobeNewswire Inc.Addiction Experts Highlight the Need for Non-Abstinence-Based Therapies to Treat Alcohol Use Disorder in Adial Pharmaceuticals Key Opinion Leader WebinarNASDAQ:ADILWAdial Pharmaceuticals Inc
24/10/202321:30GlobeNewswire Inc.Adial Pharmaceuticals Announces Closing of $4 Million Private Placement Priced At-The-Market Under Nasdaq RulesNASDAQ:ADILWAdial Pharmaceuticals Inc
20/10/202313:00GlobeNewswire Inc.Adial Pharmaceuticals Announces $4 Million Private Placement Priced At-The-Market Under Nasdaq RulesNASDAQ:ADILWAdial Pharmaceuticals Inc
19/10/202315:30GlobeNewswire Inc.Adial Pharmaceuticals Awarded Notice of Allowance for Key Patent Combining Use of the Company’s Proprietary Genetic Diagnostic with AD04 to Treat Alcohol and Drug DependenceNASDAQ:ADILWAdial Pharmaceuticals Inc
18/10/202313:00GlobeNewswire Inc.Adial Pharmaceuticals Wins Frost & Sullivan's 2023 North American Precision Medicine for Addiction Disorders Technology Innovation Leadership AwardNASDAQ:ADILWAdial Pharmaceuticals Inc
28/09/202312:00GlobeNewswire Inc.Adial Pharmaceuticals to Host a Virtual Key Opinion Leader Webinar to Discuss the Unmet Need in Alcohol Use DisorderNASDAQ:ADILWAdial Pharmaceuticals Inc
05/09/202313:30GlobeNewswire Inc.Adial Pharmaceuticals to Present at the H.C. Wainwright 25th Annual Global Investment ConferenceNASDAQ:ADILWAdial Pharmaceuticals Inc
28/08/202313:30GlobeNewswire Inc.Adial Pharmaceuticals Chief Medical Officer and Key Opinion Leaders to Discuss the Need for New Alcohol Use Disorder Treatments at the European Society for Biomedical Research on AlcoholismNASDAQ:ADILWAdial Pharmaceuticals Inc
23/08/202313:30GlobeNewswire Inc.Adial Pharmaceuticals Regains Compliance with Nasdaq Listing RequirementsNASDAQ:ADILWAdial Pharmaceuticals Inc
21/08/202313:30GlobeNewswire Inc.Adial Pharmaceuticals Reports Second Quarter 2023 Financial Results and Provides Business UpdateNASDAQ:ADILWAdial Pharmaceuticals Inc
04/08/202313:30GlobeNewswire Inc.Adial Pharmaceuticals Announces Reverse Stock Split to Regain Compliance with Nasdaq’s Minimum Bid Price Requirement and Reduce the Public FloatNASDAQ:ADILWAdial Pharmaceuticals Inc
11/07/202313:30GlobeNewswire Inc.Adial Provides Business Update Following Favorable Comments from US and EU Regulatory MeetingsNASDAQ:ADILWAdial Pharmaceuticals Inc
01/06/202314:00GlobeNewswire Inc.Adial Pharmaceuticals to Present at the 2023 Jefferies Global Healthcare Conference on June 9thNASDAQ:ADILWAdial Pharmaceuticals Inc
12/05/202313:30GlobeNewswire Inc.Adial Pharmaceuticals Reports First Quarter 2023 Financial Results and Provides Business UpdateNASDAQ:ADILWAdial Pharmaceuticals Inc
10/05/202313:30GlobeNewswire Inc.Adial Pharmaceuticals Receives Notice of Exercise from Adovate for the Acquisition of Purnovate’s Assets and BusinessNASDAQ:ADILWAdial Pharmaceuticals Inc
30/03/202321:05GlobeNewswire Inc.Adial Pharmaceuticals Reports 2022 Fiscal Year Financial Results and Provides Business UpdateNASDAQ:ADILWAdial Pharmaceuticals Inc
 Showing the most relevant articles for your search:NASDAQ:ADILW

Your Recent History

BIT
P1PIB0
BNP Paribas Issuance
BIT
P1QLG1
BNP Paribas Issuance
Delayed Upgrade Clock
    ADVFN Logo
    InvestorsHub

    United Kingdom
    Company
    Business
    Popular
    Get The App
    App Store
    Google Play

    Support: +44 (0) 203 8794 460 | support@advfn.com

    By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

    © 2024 ADVFN PLC - All Rights Reserved